NanoViricides
NNVC
#10154
Rank
โ‚ฌ27.47 M
Marketcap
1,27ย โ‚ฌ
Share price
-14.94%
Change (1 day)
8.67%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): -0,56ย โ‚ฌ

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -0,52ย โ‚ฌ. an increase over its 2024 EPS that were of -0,60ย โ‚ฌ.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025-0,54ย โ‚ฌ-10%
2024-0,60ย โ‚ฌ-5.41%
2023-0,64ย โ‚ฌ5.71%
2022-0,60ย โ‚ฌ-13.58%
2021-0,70ย โ‚ฌ-66.11%
2020-2,05ย โ‚ฌ1.7%
2019-2,02ย โ‚ฌ-10.98%
2018-2,27ย โ‚ฌ-22.35%
2017-2,92ย โ‚ฌ-10.53%
2016-3,27ย โ‚ฌ375%
2015-0,69ย โ‚ฌ-85.19%
2014-4,64ย โ‚ฌ42.11%
2013-3,27ย โ‚ฌ26.67%
2012-2,58ย โ‚ฌ-6.25%
2011-2,75ย โ‚ฌ14.28%
2010-2,41ย โ‚ฌ100%
2009-1,20ย โ‚ฌ-0%
2008-1,20ย โ‚ฌ-33.33%
2007-1,81ย โ‚ฌ-0%
2006-1,81ย โ‚ฌ4445.07%
2005-0,03973ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
5,89ย โ‚ฌ-1,222.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3,06ย โ‚ฌ-683.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
3,06ย โ‚ฌ-683.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,34ย โ‚ฌ-737.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
2,36ย โ‚ฌ-549.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
1,07ย โ‚ฌ-304.92%๐Ÿ‡บ๐Ÿ‡ธ USA